Overview

TROG 20.01 CHEST RT: Chemotherapy and Immunotherapy in Extensive Stage Small Cell Lung Cancer With Thoracic Radiotherapy

Status:
Recruiting
Trial end date:
2026-07-31
Target enrollment:
Participant gender:
Summary
Chemotherapy and Immunotherapy in extensive stage small cell lung cancer with thoracic radiotherapy
Phase:
Phase 2
Details
Lead Sponsor:
Trans Tasman Radiation Oncology Group
Collaborator:
AstraZeneca